During a recent podcast with The Journal of Healthcare Contracting, publisher John Pritchard interviewed clinical supply chain leaders from hospitals and health systems about how hospitals must engage multiple departments to manage risks, communicate changes, and ensure safe product use.
These leaders discussed patient safety and environmental sustainability, as well as how they were assessing new patient safety legislation in California, the Toxic Free Medical Device Act or AB 2300, and its potential impact on the IV therapy products they utilize at their facilities.